CLB-016
CLB-016 is a potent Hypoxia-inducible factor (HIF-1) inhibitor with an IC50 of 19.1 μM. CLB-016 significantly suppresses HIF-1-mediated hypoxia response[1].
Product Specifications
CAS Number
[1005636-29-2]
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/clb-016.html
Smiles
O=C(C1=NN(CC)C=C1NC(C2=CC=C(CN3N=C(C)C=C3C)O2)=O)N
Molecular Formula
C17H20N6O3
Molecular Weight
356.38
References & Citations
[1]Yasuda Y, et al. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF) -1 inhibitors. Bioorg Med Chem. 2015 Apr 15;23 (8) :1776-87.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6353414-01 0.2 mL
TAF6L, NT (TAF6L, PAF65A, TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65kD subunit 6L, PCAF-associated factor 65-alpha) (APC)
Ask
View Details 
MBS6353414-02 5x 0.2 mL
TAF6L, NT (TAF6L, PAF65A, TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65kD subunit 6L, PCAF-associated factor 65-alpha) (APC)
Ask
View Details